Clinical Trials Directory

Trials / Unknown

UnknownNCT02238587

The Effect of Ganoderma on Patients With Head-and-neck Cancer

The Effect of Gandoerma Spores Powder Capsules on the Post-treatment Life Quality and Immune Modulation of the Patients With Head-and-neck Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Chang Bing Show Chwan Memorial Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiotherapy and/or chemotherapy)

Detailed description

Ganoderma is known to modulate immunity and improve health. However, the mechanism is not clear. We hypothesize that patients who have completed standard treatment with/without radiotherapy might require biological modifier such as Ganoderma to improve life quality and immunity status. A total of 100 patients are randomized to study and control groups. In study group, Ganoderma Spores Powder Capsules are given to the patients for 6 weeks, In control group, only placebos are given during the same period. Then the patients in study and control groups are switched, Ganoderma Spores Powder Capsules and placebos are given for 6 weeks. The data pertaining to their Life quality are collected using Quality of Life Questionnaire after the first 6 weeks and the second 6 weeks. The immunity status is also studied at the same time.

Conditions

Interventions

TypeNameDescription
OTHERControl groupIn control group, only placebos are given for 6 weeks. The patients who are in control groups are switched to receive Ganoderma Spores Powder Capsules for 6 weeks.
DIETARY_SUPPLEMENTGanoderma Spores Powder CapsulesIn experimental group, Ganoderma Spores Powder Capsules for 12 weeks.

Timeline

Start date
2014-06-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-09-12
Last updated
2014-09-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02238587. Inclusion in this directory is not an endorsement.